Neuregulin-1 (NRG1) is a crucial signaling protein belonging to the epidermal growth factor (EGF) family, exerting diverse effects on cellular processes during development and adulthood. Primarily expressed in the nervous system, heart, and other tissues, NRG1 plays pivotal roles in neural development, cardiomyocyte function, and the maintenance of various organ systems. In the nervous system, NRG1 acts as a key mediator of neurodevelopmental processes, including neuronal migration, axon guidance, and synapse formation. It also promotes the survival and differentiation of both neurons and glial cells, contributing to the establishment of functional neural circuits. Furthermore, NRG1 signaling is implicated in synaptic plasticity, influencing neurotransmission and synaptic strength, which underlie learning and memory processes.
Activation of Neuregulin-1 occurs through complex mechanisms involving interactions with its cognate receptors, ErbB tyrosine kinase receptors (ErbB2, ErbB3, and ErbB4). Binding of NRG1 to ErbB receptors initiates intracellular signaling cascades that regulate diverse cellular responses. Upon ligand binding, ErbB receptors undergo dimerization and autophosphorylation, leading to the activation of downstream signaling pathways such as the PI3K-Akt and MAPK-ERK pathways. These pathways mediate various cellular processes, including cell survival, proliferation, and differentiation, ultimately contributing to the biological effects of NRG1. Additionally, NRG1 signaling can be modulated by factors such as proteolytic processing and alternative splicing, which generate diverse isoforms with distinct signaling properties. Overall, the activation of Neuregulin-1 plays a critical role in orchestrating cellular processes essential for normal development and tissue homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a histone deacetylase (HDAC) inhibitor. By inhibiting HDAC, it promotes histone acetylation and facilitates the transcription of Neuregulin-1, leading to increased expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol, an activator of SIRT1, indirectly influences Neuregulin-1 expression. SIRT1 activation modulates chromatin structure and promotes Neuregulin-1 gene transcription. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Cisplatin induces ER stress, and the unfolded protein response (UPR) associated with ER stress can influence Neuregulin-1 expression. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $70.00 $198.00 | 18 | |
SB216763 is a GSK-3β inhibitor. Inhibition of GSK-3β can positively regulate Neuregulin-1 expression, as GSK-3β negatively regulates factors that influence Neuregulin-1 transcription. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB431542 is a selective inhibitor of the TGF-β receptor kinase. Inhibition of TGF-β signaling by SB431542 can positively regulate Neuregulin-1 expression, as TGF-β negatively regulates factors influencing Neuregulin-1 transcription. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG-132 is a proteasome inhibitor. Inhibition of the proteasome can stabilize factors that positively regulate Neuregulin-1, leading to increased expression. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin induces ER stress by inhibiting the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) pump. ER stress triggers the unfolded protein response (UPR), which can impact Neuregulin-1 expression. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
KN-93 is a CaMKII inhibitor. Inhibition of CaMKII can negatively regulate Neuregulin-1 expression, as CaMKII is involved in signaling cascades that influence Neuregulin-1 transcription. | ||||||